We performed a retrospective study of a large cohort of patients who had ep
isodes of Staphylococcus aureus bacteremia (SAB) from January 1995 through
February 1999 at 1 medical center to identify predictors of 30-day mortalit
y in SAB. Among 293 patients with episodes of SAB, 68 died (23.2%) within 3
0 days of onset. There was no significant difference in 30-day mortality as
sociated with treatment with vancomycin, a beta -lactam, or a miscellaneous
group of antimicrobial agents (P =.180), By logistic regression, an acute
physiology score Ca component of the acute physiology and chronic health ev
aluation [APACHE III]) >60 at onset of SAB was the most important predictor
of 30-day mortality (odds ratio [OR], 15.7). Other significant predictors
were lung (OR, 5.8) or unknown (OR, 4.1) focus of SAB, age greater than or
equal to 65 years (OR, 2.0), and diabetes mellitus (OR, 2.4). Future invest
igators of SAB should take into consideration acute severity of illness at
onset as well as other factors when evaluating or comparing outcomes.